Evidence map›Paper›PMID 34229162›Full record

ReviewCurrent opinion in chemical biology2021

Exploring amyloid oligomers with peptide model systems.

Tuan D Samdin, Adam G Kreutzer, James S Nowick

Open access · hybridAbstract readReview
In one paragraph

Review in Current opinion in chemical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Dissecting the Conformational Stability of a Glycan Hairpin.Journal of the American Chemical Society · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Synthesis of a glycan hairpin.Nature chemistry · 2023
    Article
  13. Probing differences among Aβ oligomers with two triangular trimers derived from Aβ.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Tuan D SamdinDepartment of Chemistry, University of California, Irvine, CA 92697-2025, United States.
Adam G KreutzerDepartment of Chemistry, University of California, Irvine, CA 92697-2025, United States.
James S NowickDepartment of Chemistry, University of California, Irvine, CA 92697-2025, United States; Department of Pharmaceutical Sciences, University of California, Irvine, CA 92697-2025, United States. Electronic address: jsnowick@uci.edu.
University of California, Irvine · US

Funding

Antibodies Against Conformationally Defined Amyloid Oligomers in Alzheimer’s DiseaseRF1AG062296 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI NOWICK, JAMES S · 2018 to 2018
$3.0M
Purchase of an Microwave Peptide SynthesizerR01GM097562 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI NOWICK, JAMES S · 2012 to 2019
$2.5M
NIA NIH HHS RF1 AG062296NIGMS NIH HHS R01 GM097562
6 · The paper itself

Abstract

The assembly of amyloidogenic peptides and proteins, such as the β-amyloid peptide, α-synuclein, huntingtin, tau, and islet amyloid polypeptide, into amyloid fibrils and oligomers is directly linked to amyloid diseases, such as Alzheimer's, Parkinson's, and Huntington's diseases, frontotemporal dementias, and type II diabetes. Although amyloid oligomers have emerged as especially important in amyloid diseases, high-resolution structures of the oligomers formed by full-length amyloidogenic peptides and proteins have remained elusive. Investigations of oligomers assembled from fragments or stabilized β-hairpin segments of amyloidogenic peptides and proteins have allowed investigators to illuminate some of the structural, biophysical, and biological properties of amyloid oligomers. Here, we summarize recent advances in the application of these peptide model systems to investigate and understand the structures, biological properties, and biophysical properties of amyloid oligomers.

Indexed as

AmyloidDiabetes Mellitus, Type 2Amyloid beta-PeptidesCrystallography, X-RayHumansModels, MolecularPeptide FragmentsAmyloidAmyloid beta-PeptidesPeptide FragmentsAmyloidAmyloidogenic peptides and proteinsAmyloid oligomersCryoEMFibrilsHuman prion protein hPrPMacrocyclic β-hairpin peptidesModel peptide systemsMolecular dockingMolecular modelingNMROligomer mimicsPeptide fragmentsStabilized β-hairpinsSuperoxide dismutase 1 (SOD1)X-ray crystallographyαB crystallinα-Synucleinβ-amyloid peptide (Aβ)

Identifiers

PMID34229162
PMCPMC9042423
OpenAlexW3177875892

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.